prescription costs

Nosse Wants Law to Track Biosimilar Drugs Without Restricting Access

An ongoing controversy over generic equivalents to complex biological drugs is resurfacing in the 2016 session, as patient advocacy groups and drug companies try again to require pharmacists to take extra steps to notify prescribers of a substitution when they dispense something other than a brand-name biological drug.

Rep. Rob Nosse, D-Portland, is bringing back a bill that requires pharmacists to give extra notification to medication prescribers when the pharmacist dispenses a cheaper, biosimilar equivalent to a brand-name biological drug.

Subscribe to prescription costs